42 related articles for article (PubMed ID: 37022995)
1. Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancer.
Leung ML; Davis A; Gao R; Casasent A; Wang Y; Sei E; Vilar E; Maru D; Kopetz S; Navin NE
Genome Res; 2017 Aug; 27(8):1287-1299. PubMed ID: 28546418
[TBL] [Abstract][Full Text] [Related]
2. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
[TBL] [Abstract][Full Text] [Related]
3. BREAST CANCER HISTOPATHOLOGY IMAGE ANALYSIS PIPELINE FOR TUMOR PURITY ESTIMATION.
Azimi V; Chang YH; Thibault G; Smith J; Tsujikawa T; Kukull B; Jensen B; Corless C; Margolin A; Gray JW
Proc IEEE Int Symp Biomed Imaging; 2017 Apr; 2017():1137-1140. PubMed ID: 30364881
[TBL] [Abstract][Full Text] [Related]
4. On-chip modeling of tumor evolution: Advances, challenges and opportunities.
Li C; Holman JB; Shi Z; Qiu B; Ding W
Mater Today Bio; 2023 Aug; 21():100724. PubMed ID: 37483380
[TBL] [Abstract][Full Text] [Related]
5. Cellular and Molecular Mechanisms of the Tumor Stroma in Colorectal Cancer: Insights into Disease Progression and Therapeutic Targets.
Shakhpazyan N; Mikhaleva L; Bedzhanyan A; Gioeva Z; Sadykhov N; Mikhalev A; Atiakshin D; Buchwalow I; Tiemann M; Orekhov A
Biomedicines; 2023 Aug; 11(9):. PubMed ID: 37760801
[TBL] [Abstract][Full Text] [Related]
6. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.
Tbeileh N; Timmerman L; Mattis AN; Toriguchi K; Kasai Y; Corvera C; Nakakura E; Hirose K; Donner DB; Warren RS; Karelehto E
PLoS One; 2023; 18(4):e0271354. PubMed ID: 37022995
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.
Lim B; Mun J; Kim JH; Kim CW; Roh SA; Cho DH; Kim YS; Kim SY; Kim JC
Oncotarget; 2015 Sep; 6(26):22179-90. PubMed ID: 26109429
[TBL] [Abstract][Full Text] [Related]
8. Single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer tumors.
Wang R; Li J; Zhou X; Mao Y; Wang W; Gao S; Wang W; Gao Y; Chen K; Yu S; Wu X; Wen L; Ge H; Fu W; Tang F
Genome Med; 2022 Aug; 14(1):93. PubMed ID: 35974387
[TBL] [Abstract][Full Text] [Related]
9. Single-cell exome sequencing reveals multiple subclones in metastatic colorectal carcinoma.
Tang J; Tu K; Lu K; Zhang J; Luo K; Jin H; Wang L; Yang L; Xiao W; Zhang Q; Liu X; Ge XY; Li G; Zhou Z; Xie D
Genome Med; 2021 Sep; 13(1):148. PubMed ID: 34507604
[TBL] [Abstract][Full Text] [Related]
10. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
[TBL] [Abstract][Full Text] [Related]
11. Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study.
Ghazani AA; Oliver NM; St Pierre JP; Garofalo A; Rainville IR; Hiller E; Treacy DJ; Rojas-Rudilla V; Wood S; Bair E; Parello M; Huang F; Giannakis M; Wilson FH; Stover EH; Corsello SM; Nguyen T; Rana HQ; Church AJ; Lowenstein C; Cibulskis C; Amin-Mansour A; Heng J; Brais L; Santos A; Bauer P; Waldron A; Lo P; Gorman M; Lydon CA; Welch M; McNamara P; Gabriel S; Sholl LM; Lindeman NI; Garber JE; Joffe S; Van Allen EM; Gray SW; Ja Nne PA; Garraway LA; Wagle N
Genet Med; 2017 Jul; 19(7):787-795. PubMed ID: 28125075
[TBL] [Abstract][Full Text] [Related]
12. Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features.
Mendelaar PAJ; Smid M; van Riet J; Angus L; Labots M; Steeghs N; Hendriks MP; Cirkel GA; van Rooijen JM; Ten Tije AJ; Lolkema MP; Cuppen E; Sleijfer S; Martens JWM; Wilting SM
Nat Commun; 2021 Jan; 12(1):574. PubMed ID: 33495476
[TBL] [Abstract][Full Text] [Related]
13. Biased Influences of Low Tumor Purity on Mutation Detection in Cancer.
Cheng J; He J; Wang S; Zhao Z; Yan H; Guan Q; Li J; Guo Z; Ao L
Front Mol Biosci; 2020; 7():533196. PubMed ID: 33425983
[TBL] [Abstract][Full Text] [Related]
14. Systematic Assessment of Tumor Purity and Its Clinical Implications.
Haider S; Tyekucheva S; Prandi D; Fox NS; Ahn J; Xu AW; Pantazi A; Park PJ; Laird PW; Sander C; Wang W; Demichelis F; Loda M; Boutros PC;
JCO Precis Oncol; 2020; 4():. PubMed ID: 33015524
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
